Navigation Links
Improvements in embryonic preimplantation genetic screening techniques
Date:4/13/2011

A Short Comparative Genomic Hybridisation (CGH) method has been developed to carry out preimplantation genetic screening (PGS) by analysing all chromosomes and transferring selected embryos to the recipient uterus in the same in vitro fertilisation cycle. This eliminates the need to freeze them.

The technique has been applied to the screening of chromosomal anomalies in cases of advanced maternal age, recurrent miscarriages or repeated implantation failures.

Short-CGH achieved, as part of a PGS programme, the pregnancy of a woman whose partner is carrier of two chromosomal translocations, a very rare case which commonly causes infertility, miscarriages or physical and/or mental malformations in the newborn.

The technique developed is the result of a doctoral thesis by Mariona Rius, member of the research team belonging to the Cell Biology and Medical Genetics Unit of the Department of Cell Biology, Physiology and Immunology at Universitat Autnoma de Barcelona (UAB). The project received funding from the Spanish Health Research Fund and was carried out under the Eugin Research Chair - UAB.

Preimplantation Genetic Screening (PGS), through in vitro fertilisation (IVF) treatment, allows selecting healthy embryos with no anomalies which are later transferred to the recipient uterus, thus increasing chances of implantation.

Presently, the methodology most frequently used is the analysis of one cell of the embryo the third day of its development through fluorescent in situ hybridisation (FISH), which routinely analyses only nine of the 24 different types of existing chromosomes. The selected embryos are transferred to the recipient uterus four days after beginning, in the same IVF cycle. The implantation rate using this technique is 14%.

An alternative technique, used in few centres in the world, is Comparative Genomic Hybridisation (CGH) which allows for a comprehensive cytogenetic analysis of all chromosomes to check for anomalies of full chromosomes (aneuploidy) or only of parts. This methodology, however, is highly complex and needs more time than the IVF cycle to yield results (72 hours). Therefore, the embryos analysed must be cryopreserved and transferred in a subsequent IVF cycle, which could affect their viability. The implantation rate using this technique ranges from 40 to 70 %.

In her doctoral thesis, Mariona Rius developed a short-CGH method which allows the full karyotype study of the cell (blastomere) with a very reduced hybridisation period (from 72 to 12 hours). Using only one procedure and with the same efficacy, short-CGH permits scientists to detect not only aberrations in the number of chromosomes (numerical), but also alterations in chromosome fragments (structural). Thus the embryos selected chromosomally normal can be transferred within the same IVF cycle.

The technique was applied clinically in the screening of chromosomal abnormalities in cases of advanced maternal age, recurrent miscarriages or repeated implantation failures. The implantation rate of transferred embryos reached 60%. It was also used, for the first time in a PGS programme, to obtain a successful pregnancy of a woman whose partner is carrier of two chromosomal translocations, one reciprocal and the other Robertsonian. This is a very rare case which frequently causes infertility, miscarriages or physical and/or mental malformations in the newborn. Of the 16 embryos analysed in three consecutive IVF cycles, the only embryo without chromosomal imbalances was transferred to the woman, who is currently in the third trimester of her pregnancy.

Given the results obtained in this first research phase, researchers are confident that the short-CGH method will be applied in more PGS tests.


'/>"/>

Contact: Maria Jesus Delgado
MariaJesus.Delgado@uab.cat
34-935-814-049
Universitat Autonoma de Barcelona
Source:Eurekalert

Related biology news :

1. Microreactors: Small scale chemistry could lead to big improvements for biodegradable polymers
2. Key nutrient in maternal diet promises dramatic improvements for people with Down syndrome
3. Womens support groups make dramatic improvements on neonatal survival rates
4. Repulsion more important than cohesion in embryonic tissue separation
5. States now fund majority of human embryonic stem cell research
6. Research!America asks Congress to support embryonic stem cell research now
7. Congressman, CSHL president urge quick action to reverse judicial embryonic stem cell research ban
8. Ronin recruits protein allies to sustain embryonic stem cell growth
9. New culture dish could advance human embryonic stem cell research
10. UCI researchers create retina from human embryonic stem cells
11. Study finds protein that plays key role in early embryonic development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/7/2016)... , June 7, 2016  Syngrafii Inc. ... a business relationship that includes integrating Syngrafii,s patented ... branch project. This collaboration will result in greater ... the credit union, while maintaining existing document workflow ... http://photos.prnewswire.com/prnh/20160606/375871LOGO ...
(Date:6/2/2016)...   The Weather Company , an IBM Business (NYSE: ... capability in which consumers will be able to interact with ... via voice or text and receive relevant information about the ... Marketers have long sought an advertising solution that can create ... relevant and valuable; and can scale across millions of interactions ...
(Date:5/24/2016)... -- Ampronix facilitates superior patient care by providing unparalleled technology to leaders of the ... latest premium product recently added to the range of products distributed by Ampronix. ... ... ... Display- Ampronix News ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... /PRNewswire/ - FACIT has announced the creation of ... company, Propellon Therapeutics Inc. ("Propellon" or "the Company"), ... portfolio of first-in-class WDR5 inhibitors for the treatment ... represent an exciting class of therapies, possessing the ... cancer patients. Substantial advances have been achieved with ...
(Date:6/23/2016)... MONICA, Calif. , June 23, 2016  The Prostate Cancer Foundation ... pioneer increasingly precise treatments and faster cures for prostate cancer. Members of the ... institutions across 15 countries. Read More About the Class ... ... ...
(Date:6/23/2016)... ... June 23, 2016 , ... STACS DNA Inc., the sample ... the Arkansas State Crime Laboratory, has joined STACS DNA as a Field Application Specialist. ... said Jocelyn Tremblay, President and COO of STACS DNA. “In further expanding our capacity ...
(Date:6/23/2016)... 2016 Andrew D ... http://doi.org/10.17925/OHR.2016.12.01.22 Published recently in ... from touchONCOLOGY, Andrew D Zelenetz , discusses ... care is placing an increasing burden on healthcare ... therapies. With the patents on many biologics expiring, ...
Breaking Biology Technology: